Coastal erosion control is essential for protecting pharmaceutical facilities and the natural resources that underpin drug discovery and production. Many pharmaceutical companies operate near coastal areas to access seawater for research, cooling, and raw material extraction. However, coastal erosion—caused by rising sea levels, storms, and human activity—can lead to land loss, increased sedimentation, and contamination of water supplies. Effective coastal erosion control measures, such as the construction of seawalls, dune restoration, and the use of living shorelines with native vegetation, help stabilize these areas. This protection safeguards pharmaceutical infrastructure and preserves water quality, which is critical for manufacturing processes and environmental compliance.
In addition to infrastructure protection, coastal erosion control supports biodiversity conservation, which is vital for pharmaceutical innovation. Coastal ecosystems, including mangroves and salt marshes, often serve as reservoirs of bioactive compounds used in drug development. By controlling erosion, these habitats are maintained, allowing continuous access to valuable natural products. Moreover, controlling coastal erosion aligns with pharmaceutical companies’ sustainability commitments by reducing environmental damage and enhancing resilience against climate change. Integrating coastal erosion control into site planning and environmental management helps ensure stable, sustainable operations that protect both the pharmaceutical supply chain and the surrounding ecosystems.
Title : The cost and severity of extreme natural disasters: What they mean for society and insurance
Giuseppe Orlando, Universita degli Studi di Bari “Aldo Moro”, Italy
Title : Advancing sustainable aviation fuels: Integrated pathways, analytical validation, and scalable commercialisation
Sanjeev Gajjela, Tomato Sustainables LTD, United Kingdom
Title : Synergistic integration of photobioreactors and constructed wetlands for reclaimed water production
Antonio Albuquerque, University of Beira Interior, Portugal
Title : The business logic of service-oriented transformation of urban energy systems
Oleksandr Novoseltsev, General Energy Institute of the National Academy of Sciences of Ukraine, Ukraine
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model and a Strategic case to secure the human healthcare and wellness via Re-shaping ecosystems and stabilizing the climate
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young communicating climate change on social media: Facts and proposals
Carme Ferre Pavia, Universitat Autònoma de Barcelona, Spain